00Pricing

    Platform Offerings.

    A la carte modules. Bundle any combination for teams operating across discovery, submission, and business development.

    Current Modules

    Choose the modules you need today. Add more as your program evolves.

    Available modules

    IND Module

    Readiness and submission prep for IND packages.

    NDA Module

    Filing-gate intelligence and approval risk modeling.

    ANDA Module

    Generic pathway readiness for ANDA submissions.

    BLA Module

    End-to-end biologics readiness across CMC and regulatory.

    Device Readiness Module

    Traditional 510(k) readiness for Class II medical devices.

    Asset Acquisition Module

    Diligence and investment decisioning for BD teams.

    Platform capabilities

    • Evidence-backed intelligence and citations
    • Executive and reviewer views
    • Guided onboarding
    • Priority support

    IND Readiness·NDA Readiness·Asset Acquisition·Device Readiness

    01Extend the platform

    Available as add-ons.

    Optional services that layer onto any Platform license. Bring them in when you need them, skip them when you don't.

    Add-on

    Regulatory consulting hours

    On-demand reg strategists who plug into your workspace for IND, NDA, and ANDA questions. Bill by retainer or by engagement, not by seat.

    Add-on

    Document authoring and eCTD publishing

    Authoring and publishing partners integrated with your Alenvo workspace so scores, gaps, and priorities flow straight into the deliverable.

    Add-on

    Dedicated onboarding and enablement

    White-glove rollout, reviewer training, and executive readouts for teams standardizing Alenvo across multiple programs.

    Add-ons require an active Platform license. Talk to us about bundling during your demo.

    Have questions? Read the full Alenvo FAQ.

    Alenvo, Inc.

    Regulatory intelligence built for the highest-stakes moments in drug development.

    From first-in-human to first approval. Two products covering IND readiness and NDA filing-gate intelligence across 505(b)(1), 505(b)(2), and biosimilar pathways.

    © 2026 Alenvo, Inc. All rights reserved.

    Built for biotech and pharmaceutical regulatory affairs teams.